Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Background/objectives Reduced consumption of trans-fatty acids (TFA) is desirable to lower coronary heart disease (CHD) risk. In practice, partially hydrogenated vegetable oils (PHVO) that contain both TFAs and other fatty acids are the unit of replacement and could be replaced with diverse alternative fats and oils. We performed quantitative estimates of CHD effects if a person's PHVO consumption were to be replaced with alternative fats and oils based on (1) randomized dietary trials and (2) prospective observational studies.Subjects/methods We performed meta-analyses of (1) the effects of TFAs on blood lipids and lipoproteins in controlled dietary trials and (2) associations of habitual TFA consumption with CHD outcomes in prospective cohort studies. On the basis of these results and corresponding findings for saturated fatty acids (SFA), cis-monounsaturated fatty acids (MUFA) and cis-polyunsaturated fatty acids (PUFA), we calculated the effects on CHD risk for replacing 7.5% of energy from three different PHVO formulations (containing 20, 35 or 45% TFAs) with butter, lard, palm or vegetable oils.Results In controlled trials, each 1% energy replacement of TFAs with SFAs, MUFAs or PUFAs, respectively, decreased the total cholesterol (TC)/high-density lipoprotein cholesterol (HDL-C) ratio by 0.31, 0.54 and 0.67; the apolipoprotein (Apo)-B/ApoAI ratio by 0.007, 0.010 and 0.011; and lipoprotein (Lp)(a) by 3.76, 1.39 and 1.11 mg/l (P<0.05 for each). We also included possible effects on C-reactive protein (CRP) of TFAs vs other fats from one trial. On the basis of these risk factor changes in controlled trials, CHD risk would be variably decreased by different fats and oils replacing 7.5% of energy from 20% TFA PHVO (CHD risk reduction: -2.7% (butter) to -9.9% (canola)); 35% TFA PHVO (-11.9% (butter) to -16.0% (canola)); or 45% TFA PHVO (-17.6% (butter) to -19.8% (canola)). In prospective cohort studies, each 2% energy replacement of TFAs with SFAs, MUFAs or PUFAs would lower CHD risk by 17% (95% confidence interval (CI)=7-25%), 21% (95% CI=12-30%) or 24% (95% CI=15-33%), respectively. On the basis of these associations in observational studies, CHD risk would be variably decreased by different fats and oils replacing 7.5% of energy from 20% TFA PHVO (CHD risk reduction: +0.5% (butter) to -21.8% (soybean)); 35% TFA PHVO (-14.4% (butter) to -33.4% (soybean)); or 45% TFA PHVO (-22.4% (butter) to -39.6% (soybean)). The demonstrated effects on TC/HDL-C, ApoB/ApoAI, Lp(a), and CRP in randomized feeding trials together accounted for approximately 65-80% and approximately 50% of the estimated risk reduction for replacing PHVO with animal fats and vegetable oils, respectively, that would be calculated from prospective cohort studies.Conclusions Effects on CHD risk of removing PHVO from a person's diet vary depending on the TFA content of the PHVO and the fatty acid composition of the replacement fat or oil, with direct implications for reformulation of individual food products. Accounting for the summed effects of TFAs on multiple CHD risk factors provides more accurate estimates of potential risk reduction than considering each risk factor in isolation, and approaches the estimated risk reduction derived from prospective cohort studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Replacing 1% energy of trans fatty acids with saturated, monounsaturated, or polyunsaturated fatty acids decreases the total cholesterol/HDL cholesterol ratio by 0.31, 0.54, and 0.67, respectively.283”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [283]
In the citing paper
“Substituting calories from mono- or poly-unsaturated fat with trans fatty acids increases LDL cholesterol, apolipoprotein B, triglycerides, and lipoprotein(a), and lowers plasma high-density lipoprotein cholesterol and apolipoprotein A1 levels (44).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [44]
In the citing paper
“Weight loss has a beneficial effect on lipids and lipoproteins.”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [385]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“Summary estimates were obtained using random effects meta-analysis weighted by the inverse variance log RRs of the individual studies (DerSimonian and Laird, 1986).”
MethodYusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953 · cited 2×
“For an estimated 1.2 mg/l higher CRP, the RR was 1.58 (95% CI¼1.48–1.68) (Danesh et al., 2004).”
MethodInfluentialMensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811 · cited 1×
“The effects on blood lipid concentrations of isocaloric changes between consumption of SFAs, MUFAs and PUFAs were calculated from a prior meta-analysis of randomized controlled dietary trials (Mensink et al., 2003).”
Method(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331 · cited 3×
“For a 1.33 decrease in the TC/HDL-C ratio, the relative risk (RR) of CHD (weighted across age groups) was 0.61 (95% confidence interval (CI)¼0.55–0.69) after correction for regression dilution bias (Prospective Studies Collaboration, 2007).”
BackgroundMethodInfluentialDietary Fat Intake and the Risk of Coronary Heart Disease in Women
Hu, F. B., Stampfer, M. J., Manson, J. E., Rimm, E., Colditz, G. A., Rosner, B. A., Hennekens, C. H., & Willett, W. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372102 · Cited by 1,782
Trans fatty acids and cardiovascular disease
Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054035 · Cited by 1,752 · cited 11×
“…controlled feeding trials and of associations of habitual TFA consumption with clinical endpoints in prospective cohort studies, the estimated effects on CHD risk of replacing TFAs with equivalent calories from carbohydrate or cis-unsaturated fats has been estimated (Mozaffarian et al., 2006).”
BackgroundResultInfluentialSelf-citationMensink, R. P., & Katan, M. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008163230703 · Cited by 1,424 · cited 2×
“included 66 dietary interventions (‘diets’) among men and women involving a total of 518 individuals (Laine et al., 1982; Mensink and Katan, 1990; Zock and Katan, 1992; Judd et al., 1994, 1998, 2002; Almendingen et al., 1995; Aro et al., 1997; Muller et al., 1998; Lichtenstein et al., 1999; de Roos et al., 2001; Lovej…”
BackgroundIntake of trans fatty acids and risk of coronary heart disease among women
WILLETT, W. (1993) · The Lancet · doi:10.1016/0140-6736(93)90350-p · Cited by 1,025 · cited 2×
“For example, the use of objective biomarkers of TFA consumption (for example, erythrocyte membrane levels) (Sun et al., 2007) reveals stronger associations between TFA intake and CHD risk than the use of dietary questionnaires (Willett et al., 1993; Hu et al., 1997; Oh et al., 2005).”
BackgroundLipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies
Danesh, J., Collins, R., & Peto, R. (2000) · Circulation · doi:10.1161/01.cir.102.10.1082 · Cited by 938 · cited 2×
“…TC/HDL-C, ApoB/ApoAI, Lp(a) and CRP if 7.5% of energy from PHVO were replaced with alternative fats and oils were calculated using established relationships between these risk factors and the incidence of CHD (Danesh et al., 2000, 2004; Yusuf et al., 2004; Prospective Studies Collaboration, 2007).”
BackgroundMethodInfluential
Cited by
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Authors/Task Force Members, Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., De Backer, G., Ebrahim, S., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,753
Danaei, G., Ding, E. L., Mozaffarian, D., Taylor, B., Rehm, J., Murray, C. J. L., & Ezzati, M. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000058 · Cited by 2,860
Self-citationEckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Miller, N. H., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437740.48606.d1 · Cited by 2,261
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
de Souza, R. J., Mente, A., Maroleanu, A., Cozma, A. I., Ha, V., Kishibe, T., Uleryk, E., Budylowski, P., Schünemann, H., Beyene, J., et al. (2015) · BMJ · doi:10.1136/bmj.h3978 · Cited by 1,424
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,334
Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association
Sacks, F. M., Lichtenstein, A. H., Wu, J. H. Y., Appel, L. J., Creager, M. A., Kris-Etherton, P. M., Miller, M., Rimm, E. B., Rudel, L. L., Robinson, J. G., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000510 · Cited by 1,386
EFSA Panel on Dietetic Products, N. (2010) · EFSA Journal · doi:10.2903/j.efsa.2010.1461 · Cited by 1,278
Mozaffarian, D., Micha, R., & Wallace, S. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000252 · Cited by 1,215
“For example, daily consumption of 20 g soybean oil or 30 g canola oil, as an isocaloric replacement for other macronutrients, would increase PUFA consumption by ,5%E on a 2000 kcal/d diet [43].”
MethodSelf-citation2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.003 · Cited by 1,160
Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312450228 · Cited by 863
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms
Tosti, V., Bertozzi, B., & Fontana, L. (2018) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx227 · Cited by 762
“Substituting calories from mono- or poly-unsaturated fat with trans fatty acids increases LDL cholesterol, apolipoprotein B, triglycerides, and lipoprotein(a), and lowers plasma high-density lipoprotein cholesterol and apolipoprotein A1 levels (44).”
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cifkova, R., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.007 · Cited by 691
Health effects of trans-fatty acids: experimental and observational evidence
Mozaffarian, D., Aro, A., & Willett, W. C. (2009) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602973 · Cited by 662
“Reducing TFA intake by 2%E, corresponding to the estimated average intake of industrial TFA in the USA in 1990, and replacing with a 1:1 mix of MUFA and PUFA, would reduce the total/HDL-C ratio by 0.11.”
BackgroundMethodInfluentialSelf-citationMicha, R., Khatibzadeh, S., Shi, P., Fahimi, S., Lim, S., Andrews, K. G., Engell, R. E., Powles, J., Ezzati, M., Mozaffarian, D., et al. (2014) · BMJ · doi:10.1136/bmj.g2272 · Cited by 573
Self-citationUK health performance: findings of the Global Burden of Disease Study 2010
Murray, C. J., Richards, M. A., Newton, J. N., Fenton, K. A., Anderson, H. R., Atkinson, C., Bennett, D., Bernabé, E., Blencowe, H., Bourne, R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60355-4 · Cited by 553
Gillingham, L. G., Harris‐Janz, S., & Jones, P. J. H. (2011) · Lipids · doi:10.1007/s11745-010-3524-y · Cited by 546
“The effects on CHD risk with substitution of SFA by other macronutrients continue to be a primary focus of public health agendas [14, 52, 55].”
BackgroundMicha, R., & Mozaffarian, D. (2010) · Lipids · doi:10.1007/s11745-010-3393-4 · Cited by 543
“2 Changes in blood lipid levels for consumption of saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA), or trans fatty acids (TFA) as an isocaloric replacement for carbohydrate (CHO) as a reference, based on two meta-analyses of randomized controlled feeding trials [5, 6…”
BackgroundMethodSelf-citationUnderstanding Nutritional Epidemiology and Its Role in Policy
Satija, A., Yu, E., Willett, W. C., & Hu, F. B. (2015) · Advances in Nutrition · doi:10.3945/an.114.007492 · Cited by 412
“It is estimated that a nationwide trans fat ban, by removing the remaining partially hydrogenated fats, would prevent between 6480 and 12,960 deaths from IHD annually in the United States (120).”
BackgroundInfluentialJeske, S., Zannini, E., & Arendt, E. K. (2018) · Food Research International · doi:10.1016/j.foodres.2017.03.045 · Cited by 340
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 302
Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cifkova, R., et al. (2012) · International Journal of Behavioral Medicine · doi:10.1007/s12529-012-9242-5 · Cited by 311
“67, respectively.(283) A meta-analysis of prospective cohort studies has shown that, on average, a higher trans fatty acid intake of 2% of energy increases the risk of CHD by 23%.”
Schwingshackl, L., & Hoffmann, G. (2012) · Nutrients · doi:10.3390/nu4121989 · Cited by 294
“Clarke and Mozaffarian (2009) [55] observed that replacing hydrogenated fats with MUFA (1% of TEC) resulted in advantageous changes of several CVD risk factors like TC, LDL-cholesterol, HDL-cholesterol, TG, apoproteins A-1, B as well as B/A1, and lipoprotein (a) in 12 crossover and 1 parallel designed trials.”
BackgroundMethodInfluentialTrans fatty acids: effects on metabolic syndrome, heart disease and diabetes
Micha, R., & Mozaffarian, D. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.79 · Cited by 290
Self-citationHuth, P. J., & Park, K. M. (2012) · Advances in Nutrition · doi:10.3945/an.112.002030 · Cited by 281
“However, meta-analyses of RCT have demonstrated that SF also differentially affect other lipid biomarkers including HDL-C and triglycerides (TG), depending on the macronutrient comparison (3,72,73).”
BackgroundRamsden, C. E., Hibbeln, J. R., Majchrzak, S. F., & Davis, J. M. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510004010 · Cited by 275
“‡ In a recent pooled analysis of prospective cohort studies, each 2 en % replacement of trans-fatty acids with SFA, MUFA or PUFA was associated with a 21–32 % reduction in CHD risk((66,88)), see Discussion section.”
Siri-Tarino, P. W., Chiu, S., Bergeron, N., & Krauss, R. M. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071714-034449 · Cited by 268
“%) reduction in CHD (122).”
BackgroundMethodInfluentialGebauer, S. K., Chardigny, J.-M., Jakobsen, M. U., Lamarche, B., Lock, A. L., Proctor, S. D., & Baer, D. J. (2011) · Advances in Nutrition · doi:10.3945/an.111.000521 · Cited by 263
Aranceta, J., & Pérez-Rodrigo, C. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512001444 · Cited by 255
Omega-3 fatty acid supplementation and cardiovascular disease
Jump, D. B., Depner, C. M., & Tripathy, S. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r027904 · Cited by 239
Tzoulaki, I., Elliott, P., Kontis, V., & Ezzati, M. (2016) · Circulation · doi:10.1161/circulationaha.115.008718 · Cited by 236
“the CVD benefits of replacing saturated fats with unsaturated fats.(107,108) In contrast, for fish oil, trials have collectively found null effects.”
BackgroundCoronary heart disease prevention: Nutrients, foods, and dietary patterns
Bhupathiraju, S. N., & Tucker, K. L. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.04.038 · Cited by 225
“Although benefit was greatest with replacement with plant oils, replacement with tropical oils or animal fats also showed benefit, especially for partially hydrogenated vegetable oils with high TFA (35–45%) content [42].”
BackgroundThe effectiveness of policies for reducing dietary trans fat: a systematic review of the evidence
Downs, S. M., Thow, A. M., & Leeder, S. R. (2013) · Bulletin of the World Health Organization · doi:10.2471/blt.12.111468 · Cited by 221
Nutritional challenges and health implications of takeaway and fast food
Jaworowska, A., Blackham, T., Davies, I. G., & Stevenson, L. (2013) · Nutrition Reviews · doi:10.1111/nure.12031 · Cited by 209
WHO Scientific Update on trans fatty acids: summary and conclusions
Uauy, R., Aro, A., Clarke, R., Ghafoorunissa, L'Abbé, M. R., Mozaffarian, D., Skeaff, C. M., Stender, S., & Tavella, M. (2009) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.15 · Cited by 215
“The discussion by the experts on the merits and limita tions of the analysis presented by Mozaffarian and Clarke (2009) centered on its usefulness as a risk assessment and management tool.”
BackgroundMethodSelf-citationOleogels for development of health-promoting food products
Martins, A. J., Vicente, A. A., Pastrana, L. M., & Cerqueira, M. A. (2020) · Food Science and Human Wellness · doi:10.1016/j.fshw.2019.12.001 · Cited by 186
Luo, S.-Z., Hu, X.-F., Jia, Y.-J., Pan, L.-H., Zheng, Z., Zhao, Y.-Y., Mu, D.-D., Zhong, X.-Y., & Jiang, S.-T. (2019) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2019.04.016 · Cited by 183
Trans fatty acids: Effects on cardiometabolic health and implications for policy
Micha, R., & Mozaffarian, D. (2008) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.09.008 · Cited by 179
“Compared with unsaturated fats, dietary TFA also increase serum triglycerides [18] and reduce LDL-C particle size [58].”
BackgroundSelf-citationDietary fats and cardiovascular disease: Putting together the pieces of a complicated puzzle
Michas, G., Micha, R., & Zampelas, A. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.03.013 · Cited by 173
“Meta-analyses of cohorts [34,35,46,51]; meta-analysis of RCTs [39]”
BackgroundMethodWang, Q., Afshin, A., Yakoob, M. Y., Singh, G. M., Rehm, C. D., Khatibzadeh, S., Micha, R., Shi, P., Mozaffarian, D., the Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (NutriCoDE), et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002891 · Cited by 162
Self-citationHyseni, L., Atkinson, M., Bromley, H., Orton, L., Lloyd-Williams, F., McGill, R., & Capewell, S. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.234 · Cited by 161
Anti‐Inflammatory Diet in Clinical Practice: A Review
Ricker, M. A., & Haas, W. C. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617700353 · Cited by 157
“Other oils that should be avoided—as they are proinflammatory—include soybean, cottonseed, peanut, and corn oil.(73)”
BackgroundDietary fatty acids and cardiovascular disease
Salter, A. M. (2011) · animal · doi:10.1017/s1751731111002023 · Cited by 180
“Mozaffarian and Clarke (2009) also analyzed the results of a number of short-term intervention trials, which looked at the impact of replacing partially hydrogenated vegetable oil (PHVO), with a range of other dietary fats, on blood lipids and lipoproteins and other risk factors.”
BackgroundResultInfluentialMhaimeed, O., Burney, Z. A., Schott, S. L., Kohli, P., Marvel, F. A., & Martin, S. S. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100649 · Cited by 124
“Regarding diet, consumption of unsaturated is preferred versus saturated and trans fats for managing LDL-C [40,41].”
BackgroundTrans fat and cardiovascular disease mortality: Evidence from bans in restaurants in New York
Restrepo, B., & Rieger, M. (2015) · Journal of Health Economics · doi:10.1016/j.jhealeco.2015.09.005 · Cited by 145
“In meta-analyses of dietary RCTs lasting between 17 and 70 days, Mozaffarian and Clarke (2009) find that substituting 1% of dietary energy from unsaturated fats with trans fat increases LDL by between 0.”
BackgroundRosenzweig, J. L., Bakris, G. L., Berglund, L. F., Hivert, M.-F., Horton, E. S., Kalyani, R. R., Murad, M. H., & Vergès, B. L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01338 · Cited by 126
Oleogelation: From Scientific Feasibility to Applicability in Food Products
Scharfe, M., & Flöter, E. (2020) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.202000213 · Cited by 143
Sustainable palm oil may not be so sustainable
Gatti, R. C., Liang, J., Velichevskaya, A. I., & Zhou, M. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.10.222 · Cited by 137
Kelley, G. A., Kelley, K. S., Roberts, S., & Haskell, W. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2011.11.011 · Cited by 125
Milk fat: opportunities, challenges and innovation
Mohan, M. S., O’Callaghan, T. F., Kelly, P. M., & Hogan, S. A. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1778631 · Cited by 135
“…arising from consumption of SFA as an isocaloric replacement of other food nutrients on circulating lipids and lipoproteins (Mensink et al. 2003; Mozaffarian and Clarke 2009) were revealed in a review of randomized controlled studies of disease end-points, multiple risk factors and cohort…”
BackgroundResearch advancements in palm oil nutrition
May, C. Y., & Nesaretnam, K. (2014) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201400076 · Cited by 131
“(2009) [41] also reported that a 2% increase in energy intake from partially hydrogenated fats or trans fatty acids was associated with a 23% increase in the incidence of cardiovascular heart disease.”
BackgroundAssessment of quality of edible vegetable oils accessed in Gondar City, Northwest Ethiopia
Negash, Y. A., Amare, D. E., Bitew, B. D., & Dagne, H. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4831-x · Cited by 117
Huth, P. J., Fulgoni, V. L. I., & Larson, B. T. (2015) · Advances in Nutrition · doi:10.3945/an.115.008979 · Cited by 133
“05), and nonsignificant changes in HDL cholesterol, TGs, TC:HDL cholesterol, apoB, and apoA-1 (21).”
BackgroundMethodResultInfluentialFederici, C., Detzel, P., Petracca, F., Dainelli, L., & Fattore, G. (2019) · BMC Nutrition · doi:10.1186/s40795-018-0263-6 · Cited by 135
Food Reformulations to Reduce Trans Fatty Acids
Mozaffarian, D., Jacobson, M. F., & Greenstein, J. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1001841 · Cited by 111
Self-citationMoreira, P. V. L., Baraldi, L. G., Moubarac, J.-C., Monteiro, C. A., Newton, A., Capewell, S., & O’Flaherty, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118353 · Cited by 105
“(2009)[23] Replacement of 5% energy of Saturated Fat by PUFAs Trans-Fat (% energy intake/day) Trans-fat (G3a+G3b)—Trans-fat (G1 +G2/2) Trans-fat G3b—Trans-fat (G1+G2 +G3a/3) Mozaffarian & Clark (2009)[24] -12% CHD risk by replacing 1% of energy from Trans-fat with unsaturated fats reduces”
MethodWolfram, G., Bechthold, A., Boeing, H., Ellinger, S., Hauner, H., Kroke, A., Leschik-Bonnet, E., Linseisen, J., Lorkowski, S., Schulze, M., et al. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000437243 · Cited by 94
Micha, R., King, I. B., Lemaître, R. N., Rimm, E. B., Sacks, F. M., Song, X., Siscovick, D. S., & Mozaffarian, D. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28877 · Cited by 104
Self-citationThe Role of Healthy Lifestyle in the Primordial Prevention of Cardiovascular Disease
Claas, S. A., & Arnett, D. K. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0728-7 · Cited by 103
Brouwers, J. F. H. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.08.001 · Cited by 100
Systematic review of dietary trans-fat reduction interventions
Hyseni, L., Bromley, H., Kypridemos, C., O’Flaherty, M., Lloyd‐Williams, F., Guzman-Castillo, M., Pearson‐Stuttard, J., & Capewell, S. (2017) · Bulletin of the World Health Organization · doi:10.2471/blt.16.189795 · Cited by 98
Ghorghi, Z. B., Yeganehzad, S., Hesarinejad, M. A., Faezian, A., Сергеевна, К. В., Gao, Z., Nishinari, K., & Nepovinnykh, N. V. (2023) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2023.108599 · Cited by 81
Wheat gluten based percolating emulsion gels as simple strategy for structuring liquid oil
Liu, X., Chen, X., Guo, J., Yin, S., & Yang, X. (2016) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2016.06.037 · Cited by 78
Role of cis-Monounsaturated Fatty Acids in the Prevention of Coronary Heart Disease
Joris, P. J., & Mensink, R. P. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0597-y · Cited by 77
Physico-chemical properties, fatty acid profile and nutrition in palm oil
Koushki, M. R., Nahidi, M., & Cheraghali, F. (2015) · Archives of Advances in Biosciences · doi:10.22037/jps.v6i3.9772 · Cited by 78
Wang, Y., Jácome-Sosa, M., & Proctor, S. D. (2011) · Food Research International · doi:10.1016/j.foodres.2011.08.019 · Cited by 78
Review of Fat and Fatty Acid Requirements and Criteria for Developing Dietary Guidelines
Smit, L. A., Mozaffarian, D., & Willett, W. (2009) · Annals of Nutrition and Metabolism · doi:10.1159/000228995 · Cited by 72
Self-citationRemoving industrial trans fat from foods
Mozaffarian, D., & Stampfer, M. J. (2010) · BMJ · doi:10.1136/bmj.c1826 · Cited by 70
Self-citationEffects of Dietary Fat Intake on HDL Metabolism
Yanai, H., Katsuyama, H., Hamasaki, H., Abe, S., Tada, N., & Sako, A. (2014) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2030w · Cited by 81
“Recently, TFA has been reported to adversely affect cardiovascular health, and Mozaffarian et al reviewed the evidence for effects of TFA consumption on CHD risks.”
BackgroundInfluentialPosicionamento sobre o Consumo de Gorduras e Saúde Cardiovascular – 2021
Izar, M. C. D. O., Lottenberg, A. M., Giraldez, V. Z. R., Santos, R. D., Machado, R. M., Bertolami, A., Assad, M. H. V., Saraiva, J. F. K., Faludi, A. Á., Moreira, A. S. B., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201340 · Cited by 142
Nadeem, M. F., Imran, M., Taj, I., Ajmal, M., & Junaid, M. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0490-x · Cited by 65
“The excessive intake of trans fatty acids may lead to cardiovascular diseases, cancer and inflammation [3].”
BackgroundAronis, K. N., Khan, S. M., & Mantzoros, C. S. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.040576 · Cited by 64
“In a different meta-analysis that focused on the effects of TFAs on lipid and lipoprotein profiles, 1% of total energy intake substitution of TFAs with SFA, cis MUFAs, or cis PUFAs improved the apolipoprotein B:apolipoprotein A-I ratio and also significantly decreased lipoprotein(a) concentrations (10).”
InfluentialEighteen‑carbon trans fatty acids and inflammation in the context of atherosclerosis
Valenzuela, C. A., Baker, E. J., Miles, E. A., & Calder, P. C. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.101009 · Cited by 68
Raza, G. S., Herzig, K., & Leppäluoto, J. (2021) · Journal of Dairy Science · doi:10.3168/jds.2020-19649 · Cited by 70
“Specific formulas containing long-chain PUFA, choline, folic acid, and SM were significantly associated with the highest myelin levels and cognitive scores.”
BackgroundInfluentialThe role of fats in the transition to sustainable diets
Bajželj, B., Laguzzi, F., & Röös, E. (2021) · The Lancet Planetary Health · doi:10.1016/s2542-5196(21)00194-7 · Cited by 82
Drapkina, O. M., Karamnova, N. S., Васильевна, К. А., Gornyi, B., Дадаева, В. А., Drozdova, L. Y., Yeganyan, R. A., Олеговна, Е. С., Izmailova, O. V., Lavrenova, Е. A., et al. (2021) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2021-2952 · Cited by 64
Albuquerque, T. G., Nunes, M. A., Bessada, S. M. F., Costa, H. S., & Oliveira, M. B. P. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813266-1.00014-0 · Cited by 82
Fat and Fatty Acid Intake and Metabolic Effects in the Human Body
Sanders, T. A. B. (2009) · Annals of Nutrition and Metabolism · doi:10.1159/000229001 · Cited by 59
“Compared with carbohydrate, TFA raise LDL-C, but have a similar effect as carbohydrate on HDL-C [Mensink and Katan, 1990; Nestel et al., 1992; Judd et al., 1994; Almendingen et al., 1995; Aro et al., 1997; Lichtenstein et al., 1999; Sanders et al., 2003b; Mozaffarian and Clarke, 2009].”
BackgroundMilanlouei, S., Menichetti, G., Li, Y., Loscalzo, J., Willett, W. C., & Barabási, A.-Ĺ. (2020) · Nature Communications · doi:10.1038/s41467-020-19888-2 · Cited by 67
Kupiec, M., Żbikowska, A., Marciniak-Łukasiak, K., & Kowalska, M. K. (2020) · Agriculture · doi:10.3390/agriculture10060211 · Cited by 56
“The oleic acid contained in RO reduces the risk of cardiovascular disease, including heart attack, by lowering blood pressure [6] and lowering total cholesterol [7].”
BackgroundLakshmanan, A. P., Zaidan, S. A., Bangarusamy, D. K., Al-Shamari, S. D., Elhag, W., & Terranegra, A. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.849005 · Cited by 61
“of MUFA (1% of total energy content) significantly altered various CVD risk factors, mainly complete lipid profiles and apolipoproteins (45).”
BackgroundValsta, L. M., Tapanainen, H., Sundvall, J., Laatikainen, T., Männistö, S., Pietinen, P., & Vartiainen, E. (2010) · Public Health Nutrition · doi:10.1017/s1368980010001126 · Cited by 55
“of trans fatty acids (TFA) was also taken into account in the calculations by assuming the effect of TFA on total cholesterol levels to be similar to SFA, as shown by a recent meta-analysis of thirteen dietary interventions((14)).”
MethodTechnological Approaches to Minimize Industrial Trans Fatty Acids in Foods
Menaa, F., Menaa, A., Tréton, J., & Menaa, B. (2013) · Journal of Food Science · doi:10.1111/1750-3841.12055 · Cited by 71
Trans fatty acids, insulin resistance and diabetes
Thompson, A. K., Minihane, A.-M., & Williams, C. M. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.240 · Cited by 62
“Consumption of trans fatty acids (TFA) have a more significant effect on risk of coronary heart disease than SFA intake (Mozaffarian and Clarke, 2009), but the evidence for associations between TFA and other health issues, and mechanisms which might underlie such associations, have not been fully…”
BackgroundTrans-fatty acids and nonlipid risk factors
Wallace, S. K., & Mozaffarian, D. (2009) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0064-0 · Cited by 53
Self-citationBhat, S., Maganja, D., Huang, L., Wu, J. H. Y., & Marklund, M. (2022) · Nutrients · doi:10.3390/nu14071489 · Cited by 60
Trans Fatty Acids: Are Its Cardiovascular Risks Fully Appreciated?
Nestel, P. J. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.01.020 · Cited by 62
Otite, F. O., Jacobson, M. F., Dahmubed, A., & Mozaffarian, D. (2013) · Preventing Chronic Disease · doi:10.5888/pcd10.120198 · Cited by 54
Self-citationFord, E. S., & Capewell, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065228 · Cited by 52
“5 mg/dl) [33].”
Diet and Cardiovascular Disease
Verschuren, W. M. M. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0318-2 · Cited by 53
Plasma fatty acids, oxylipins, and risk of myocardial infarction: the Singapore Chinese Health Study
Sun, Y. J., Koh, H. W. L., Choi, H., Koh, W., Yuan, J., Newman, J. W. I., Su, J., Fang, J., Ong, C. N., & van Dam, R. M. (2016) · Journal of Lipid Research · doi:10.1194/jlr.p066423 · Cited by 55
Pande, G., & Akoh, C. C. (2012) · LWT · doi:10.1016/j.lwt.2012.05.027 · Cited by 49
Nielsen, L. V., Krogager, T. P., Young, C., Ferreri, C., Chatgilialoglu, C., Jensen, O. N., & Enghild, J. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074283 · Cited by 50
Is there a role for lifestyle changes in cardiovascular prevention? What, when and how?
Masana, L., Ros, E., Sudano, I., Angoulvant, D., Ibarretxe, D., Eizagaechevarría, N. M., Arrarte, V., Quintana, A. G., Zamora, A., Silva, A. M. E., et al. (2017) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(17)30020-x · Cited by 63
Changes in fat contents of US snack foods in response to mandatory trans fat labelling
Van Camp, D., Hooker, N. H., & Lin, C.-T. J. (2012) · Public Health Nutrition · doi:10.1017/s1368980012000079 · Cited by 46
“Since the PVHO used in bakery goods are often high in TFA, even the replacement of PHVO with butter and/or tropical oils high in SFA could reasonably be expected to reduce risk of CHD based on the results found by Mozaffarian and Clarke (18) .”
ResultKey Factors Involved in Lamb Quality from Farm to Fork in Europe
Sañudo, C., Muela, E., & Campo, M. M. (2013) · Journal of Integrative Agriculture · doi:10.1016/s2095-3119(13)60629-2 · Cited by 51
Żbikowska, A., Onacik‐Gür, S., Kowalska, M. K., Żbikowska, K., & Feszterová, M. (2023) · Gels · doi:10.3390/gels9060453 · Cited by 44
Metadata
- Authors
- Mozaffarian, D., & Clarke, R.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Oxford (GB)
- Corresponding author
- Mozaffarian, D
- Venue
- European Journal of Clinical Nutrition
- Published
- 2009-05
- Volume
- 63
- Issue
- S2
- Pages
- S22-S33
- ISSN
- 0954-3007 (ISSN-L)
- 1476-5640
- OpenAlex
- W2053223480
- Cited by
- 410
- References
- 44
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 19 · 2023: 16 · 2022: 13 · 2021: 27 · 2020: 30 · 2019: 19 · 2018: 16 · 2017: 18 · 2016: 27 · 2015: 33 · 2014: 35 · 2013: 35 · 2012: 42
- FWCI
- 34.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- European Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fonterra Co-Operative Group
- National Institutes of Health (1k08hl075628-01)
- National Heart, Lung, and Blood Institute (K08-HL-075628)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- trans fatty acids, partially hydrogenated vegetable oils, coronary heart disease risk, fat replacement, saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids, serum lipids, lipoproteins, apolipoprotein B/apolipoprotein A-I ratio, lipoprotein(a), C-reactive protein, butter, lard, palm oil, vegetable oils, canola
- MeSH terms
- Animals, C-Reactive Protein, Cardiovascular Diseases, Cholesterol, Coronary Disease, Dietary Fats, Fatty Acids, Humans, Hydrogenation, Lipids, Plant Oils, Risk Factors, Trans Fatty Acids, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.